首页> 外文期刊>Cancer Management and Research >High dose vs low dose irradiation of the subventricular zone in patients with glioblastoma—a systematic review and meta-analysis
【24h】

High dose vs low dose irradiation of the subventricular zone in patients with glioblastoma—a systematic review and meta-analysis

机译:胶质母细胞瘤患者脑室下区的高剂量照射与低剂量照射—系统评价和荟萃分析

获取原文
获取外文期刊封面目录资料

摘要

Purpose: The published data indicate that the irradiation of the subventricular zone (SVZ) might play a role in the treatment of patients with glioblastoma (GBM). We aimed to determine whether radiation treatment doses (high vs low) applied to the SVZ can lead to an increase in progression free survival (PFS) and overall survival (OS). Patients and methods: We undertook a systematic review and meta-analysis according to the PICOS research criteria of patients with glioblastoma which received high doses compared to low doses in order to determine if they have a better survival in observational and experimental studies. Results: Our survey of the literature yielded 2573 unique records. After screening, 17 were assessed for eligibility, and in the end 8 were included in the qualitative and 4 in the quantitative analysis. Subjects who received higher doses of ipsilateral SVZ (iSVZ) irradiation had a statistically significant better PFS than those receiving lower doses (HR 0.58 [95% CI 0.42–0.82], p =0.002). Subjects receiving higher doses of contralateral SVZ (cSVZ) irradiation did not have a statistically significant better PFS than those receiving lower doses (HR?=0.89 [95% CI 0.35–2.26], p =0.81). Also for OS the subjects receiving higher doses to the iSVZ did not have a statistically significant better survival than those receiving lower doses (HR?=0.75 [95% CI 0.51–1.11], p =0.15). Conclusion: The data indicate a possible involvement of the SVZ in the onset and progression of the GBM, as well as a possible role of the SVZ in radiation therapy.
机译:目的:已发表的数据表明,脑室下区域(SVZ)的照射可能在胶质母细胞瘤(GBM)患者的治疗中起作用。我们旨在确定应用于SVZ的放射治疗剂量(高剂量还是低剂量)是否可以导致无进展生存期(PFS)和总体生存期(OS)的增加。患者和方法:我们根据PICOS研究标准对胶质母细胞瘤患者(接受高剂量与低剂量)进行了系统的综述和荟萃分析,以确定他们在观察和实验研究中是否具有更好的生存率。结果:我们对文献的调查产生了2573条独特的记录。筛选后,评估了17个资格,最后定性包括8个,定量分析包括4个。统计学上,接受较高剂量的同侧SVZ(iSVZ)照射的受试者的PFS优于接受较低剂量的受试者(HR 0.58 [95%CI 0.42-0.82],p = 0.002)。接受较高剂量对侧SVZ(cSVZ)照射的受试者的PFS并没有统计学上低于接受较低剂量的受试者(HR?= 0.89 [95%CI 0.35–2.26],p = 0.81)。同样对于OS,接受iSVZ较高剂量的受试者的生存率没有统计学上低于接受较低iSVZ的受试者(HR?= 0.75 [95%CI 0.51-1.11],p = 0.15)。结论:数据表明SVZ可能参与了GBM的发生和发展,以及SVZ在放射治疗中的可能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号